Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Integrated signalling pathways for mast-cell activation.

Alasdair M Gilfillan1, Christine Tkaczyk

  • 1Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10, Room 11C206, 10 Center Drive, MSC 1881, Bethesda, Maryland 20892-1881, USA. agilfillan@niaid.nih.gov

Nature Reviews. Immunology
|February 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same author

The monoclonal antibody AZD5148 confers broad protection against TcdB-diverse Clostridioides difficile strains in mice.

PLoS pathogens·2025
Same author

Epitope Conservation of AZD5148, a Broadly Neutralizing Anti-Toxin B Monoclonal Antibody, Among Diverse and Global Contemporary Clostridioides difficile Isolates.

The Journal of infectious diseases·2025
Same author

Structure of ClfA002 in Complex With Neutralizing Antibody AZD7745 Provides Insight into Its Broad Neutralization Mechanism in Staphylococcus aureus Infection.

The Journal of infectious diseases·2025
Same author

NTHi killing activity is reduced in COPD patients and is associated with a differential microbiome.

Respiratory research·2025
Same author

A fungal metabolic regulator underlies infectious synergism during Candida albicans-Staphylococcus aureus intra-abdominal co-infection.

Nature communications·2024
Same journal

A guide to CAR T cell therapies: development, current status and future prospects.

Nature reviews. Immunology·2026
Same journal

Macrophages in embryonic development.

Nature reviews. Immunology·2026
Same journal

Glycolytic capacity instructs tumour vasculature and response to immunotherapy.

Nature reviews. Immunology·2026
Same journal

Vaginal NK cells limit epithelial barrier disruption during infection.

Nature reviews. Immunology·2026
Same journal

New insights into progenitor exhausted T cell populations.

Nature reviews. Immunology·2026
Same journal

T cell engagers in autoimmune diseases.

Nature reviews. Immunology·2026
See all related articles

Mast cells, key in allergies, release mediators via IgE receptor (FcepsilonRI) signaling. Other receptors like KIT can modulate this release by influencing distinct signaling pathways.

Area of Science:

  • Immunology
  • Cell Signaling
  • Allergy Research

Background:

  • Mast-cell activation via the high-affinity IgE receptor (FcepsilonRI) is central to allergic inflammation.
  • Physiological mast cell mediator release is influenced by multiple receptors, including KIT.
  • FcepsilonRI-mediated degranulation involves two key signaling pathways: one activating phospholipase Cgamma and another activating phosphatidylinositol 3-kinase.

Purpose of the Study:

  • To review the interacting signaling pathways regulating mast cell activation.
  • To explore how receptors like KIT influence FcepsilonRI-dependent mediator release.
  • To elucidate the role of alternative pathway activation in receptor-mediated mast cell responses.

Main Methods:

  • Review of recent scientific literature on mast cell signaling.

Related Experiment Videos

  • Analysis of evidence for complementary signaling pathways.
  • Discussion of transmembrane and cytosolic adaptor molecules involved in signal transduction.

    • Main Results:

    • Evidence supports two complementary pathways (phospholipase Cgamma and phosphatidylinositol 3-kinase) in FcepsilonRI signaling.
    • KIT and other receptors can modulate FcepsilonRI-dependent mast cell mediator release.
    • The influence of KIT on FcepsilonRI signaling depends on its ability to activate these alternative pathways.

    Conclusions:

    • Interactions between FcepsilonRI and other receptors, like KIT, fine-tune mast cell responses.
    • Understanding these signaling pathway interactions is crucial for comprehending allergic inflammation.
    • The relative capacity of receptors to activate specific pathways determines their impact on mast cell mediator release.